BDBM723383 (6-(1-methyl-1H-pyrazol 4-yl)pyridazin-3-yl)(3-( 4-methyl-6-((5-methyl-1H- pyrazol-3-yl)amino) pyrimidin-2-yl)-3,8- diazabicyclo[3.2.1] octane-8-yl) methanone::US12234222, Compound I-22

SMILES Cc1cc(Nc2cc(C)[nH]n2)nc(N2CC3CCC(C2)N3C(=O)c2ccc(-c3cnn(C)c3)nn2)n1

InChI Key InChIKey=NAHKSTDKHZOXFT-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 723383   

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM723383((6-(1-methyl-1H-pyrazol 4-yl)pyridazin-3-yl)(3-( ...)
Affinity DataIC50: 2nMAssay Description:The experimental steps are as follows:(1) The test compound (the compound of the present disclosure, and compound 164 in WO2018017983A1 as a control)...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/24/2025
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM723383((6-(1-methyl-1H-pyrazol 4-yl)pyridazin-3-yl)(3-( ...)
Affinity DataIC50: 221nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/24/2025
Entry Details
US Patent